Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Rashidghamat
Mesenchymal Stem Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa: Prospects and Clinical Progress
Expert Opinion on Orphan Drugs
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Related publications
Recessive Dystrophic Epidermolysis Bullosa Inversa
Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa
New England Journal of Medicine
Medicine
Induced Pluripotent Stem Cells From Individuals With Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
271 From Clinical to Genotypic Modeling: Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
1021 Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa Patients Harboring Nonsense Mutations
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Generation of Keratinocytes From Normal and Recessive Dystrophic Epidermolysis Bullosa-Induced Pluripotent Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Translating the Combination of Gene Therapy and Tissue Engineering for Treating Recessive Dystrophic Epidermolysis Bullosa
1039 Novel Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
935 Clinical Manifestations and Quality of Life in Patients With Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology